Lisbet Ambrosius Christensen

Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial

Casper Steenholdt, Jørn Brynskov, Ole Østergaard Thomsen et al. · Gut · 2013 · 454 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double‐blind placebo‐controlled study

Søren Peter Jørgensen, Jørgen Agnholt, Henning Glerup et al. · Alimentary Pharmacology & Therapeutics · 2010 · 384 citations · Full text

Medicine, Immunology, Nutritional Sciences +11

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

Mette Julsgaard, Lisbet Ambrosius Christensen, Richard B. Gearry et al. · Gastroenterology · 2016 · 325 citations · Full text

Medicine, Immunology, Pediatrics +10

pH‐Profile and regional transit times of the normal gut measured by a radiotelemetry device

Jan Fallingborg, Lisbet Ambrosius Christensen, Margrethe Ingeman‐Nielsen et al. · Alimentary Pharmacology & Therapeutics · 1989 · 239 citations

Pharmacy, Pharmacology, Physiology +17

Very low intraluminal colonic pH in patients with active ulcerative colitis

Jan Fallingborg, Lisbet Ambrosius Christensen, Bent Ascanius Jacobsen et al. · Digestive Diseases and Sciences · 1993 · 231 citations

Medicine, Immunology, Internal Medicine +12